Drugs / Influenza VLP Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01014806 | Nov 2009 → May 2010 | influenza | Novavax | Completed | No outcome recorded |
| Phase 2 | NCT00903552 | May → Oct 2009 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza VLP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00903552 ↗ |
| Modality | Vaccine | “Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)” NCT00903552 ↗ |
| Route | Intramuscular | “administered intramuscularly (IM)” NCT01014806 ↗ |